Xponance’s Constellium CSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$503K Buy
15,788
+2,312
+17% +$74.6K ﹤0.01% 1098
2026
Q1
$331K Buy
13,476
+2,605
+24% +$62K ﹤0.01% 1210
2025
Q4
$205K Sell
10,871
-349
-3% -$5.79K ﹤0.01% 1381
2025
Q3
$167K Buy
11,220
+119
+1% +$1.7K ﹤0.01% 1386
2025
Q2
$148K Buy
11,101
+680
+7% +$7.64K ﹤0.01% 1368
2025
Q1
$105K Sell
10,421
-2,086
-17% -$22.2K ﹤0.01% 1343
2024
Q4
$128K Sell
12,507
-8,670
-41% -$107K ﹤0.01% 1339
2024
Q3
$344K Buy
21,177
+2,676
+14% +$45.4K ﹤0.01% 1048
2024
Q2
$349K Sell
18,501
-178
-1% -$3.7K ﹤0.01% 1011
2024
Q1
$413K Sell
18,679
-534
-3% -$10.3K ﹤0.01% 1001
2023
Q4
$383K Buy
19,213
+1,012
+6% +$17.7K ﹤0.01% 1007
2023
Q3
$331K Sell
18,201
-1,269
-7% -$22.4K ﹤0.01% 1016
2023
Q2
$335K Buy
+19,470
New +$299K ﹤0.01% 1027

Other funds holding CSTM

Xponance's CSTM Position: Q2 2026 in Review

Xponance increased its Constellium (CSTM) stake by 17% in Q2 2026, buying an estimated $74.6K and bringing the position to 15,788 shares worth $503K. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

Xponance first reported a position in CSTM in Q2 2023 and has held it in 13 quarters since. 388 funds tracked by Wall St. Rank hold CSTM as of Q2 2026.

  • Xponance held 15,788 shares of Constellium worth $503K as of Q2 2026.
  • Xponance bought 2,312 Constellium shares in Q2 2026, an estimated $74.6K.
  • Constellium made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1098 holding.
  • Xponance first reported a position in Constellium in Q2 2023 and has held it in 13 quarters since.
  • 388 funds tracked by Wall St. Rank held Constellium as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.